Recorded Chinese product: 注射用单磷酸阿糖腺苷注射用单磷酸阿糖腺苷
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 广东隆赋药业有限公司Chinese legal name: 广东隆赋药业有限公司
主要成分Active Ingredients
- 单磷酸阿糖腺苷Danlin Suana Tangxian Gan
药物知识说明
单磷酸阿糖腺苷是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括：单磷酸阿糖腺苷Danlin Suana Tangxian Gan。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品：单磷酸阿糖腺苷-fe4b65d2成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 注射用单磷酸阿糖腺苷) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: 单磷酸阿糖腺苷Danlin Suana Tangxian Gan.
Explore other medicines containing the same ingredient: 单磷酸阿糖腺苷 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 注射用单磷酸阿糖腺苷Recorded Chinese product: 注射用单磷酸阿糖腺苷
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100mg100 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 广东隆赋药业有限公司Chinese legal name: 广东隆赋药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10970335
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10970335
Manufacturer
Chinese legal name: 广东隆赋药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10970335
生产企业
广东隆赋药业有限公司(国产)
适应症
抗病毒药。可应用于疱疹病毒口炎、皮炎、病毒性带状疱疹等。
用法用量
临用前，每瓶加氯化钠注射液2ml溶解后肌肉注射或缓慢静脉注射，或加入氯化钠注射液100ml溶解后静脉滴注。成人按体重一次5～10mg/kg，一日一次。
不良反应
可见注射部位疼痛。极少情况下，有出现神经肌肉疼痛及关节疼痛，偶有见血小板减少、白细胞减少或骨髓巨细胞增多现象，停药后可自行恢复，为可逆性，必要时可对症治疗。不良反应程度与给药量和疗程成正相关。
禁忌
尚不明确。
注意事项
1.如注射部位疼痛，必要时可加盐酸利多卡因注射液解除疼痛症状。 2.用药过程中密切注意不良反应的发生并及时处理。
贮藏
遮光，严密，在干燥处保存。
规格
100mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.